Industry Sponsored Symposium: Treatment for Individuals Living with Achondroplasia: Practical Recommendations from the 2025 International Consensus Guidelines

Wednesday, July 30, 2025 at 6PM EDT (1 hour Webinar)

Sponsored by: BioMarin Pharmaceutical, Inc.

PROGRAM DESCRIPTION

This 1-hour Webinar is comprised of eight (8) modules, each focusing on aspects of living with achondroplasia and offering practical recommendations for treatment from the recent 2025 international guidelines.

Learning objectives:

• To provide an overview of the 2025 international consensus guidelines for vosorotide in achondroplasia
• To discuss how the guidelines provide important recommendations for vosoritide use in individuals with achondroplasia, from treatment decision-making, through initiation, follow-up and long-term monitoring
• To illuminate how the guidelines help guide clinicians, individuals, and caregivers throughout the treatment journey

SPEAKERS:

• Philippe F. Backeljauw, MD
  Cincinnati Children’s Hospital Medical Center
  University of Cincinnati College of Medicine 

  Moderator:
  Dorna Chu, PharmD
  BioMarin Pharmaceutical, Inc.

Register here

Sponsored by: BioMarin Pharmaceutical, Inc.